Lakewood Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,177
| Closed | -$247K | – | 102 |
|
|
2025
Q1 | $247K | Sell |
1,177
-407
| -26% | -$85.3K | 0.17% | 87 |
|
|
2024
Q4 | $281K | Buy |
1,584
+9
| +0.6% | +$1.6K | 0.19% | 93 |
|
|
2024
Q3 | $311K | Buy |
1,575
+7
| +0.4% | +$1.38K | 0.21% | 89 |
|
|
2024
Q2 | $269K | Buy |
1,568
+9
| +0.6% | +$1.54K | 0.19% | 97 |
|
|
2024
Q1 | $284K | Buy |
1,559
+4
| +0.3% | +$728 | 0.19% | 91 |
|
|
2023
Q4 | $241K | Sell |
1,555
-418
| -21% | -$64.8K | 0.19% | 96 |
|
|
2023
Q3 | $294K | Buy |
1,973
+5
| +0.3% | +$745 | 0.24% | 88 |
|
|
2023
Q2 | $265K | Buy |
1,968
+5
| +0.3% | +$674 | 0.21% | 93 |
|
|
2023
Q1 | $313K | Buy |
1,963
+4
| +0.2% | +$638 | 0.26% | 82 |
|
|
2022
Q4 | $317K | Buy |
+1,959
| New | +$317K | 0.26% | 76 |
|